SCHEMBL7296382

SCHEMBL7296382

C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(=O)COC)[C@H](OC(=O)CCN(C)C)[C@@]2(C)O1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 5/20 0.84
CYP3A4 P08684 4/20 0.84
TSHR P16473 3/20 0.84
NR1I2 O75469 2/20 0.84
ADRA1A P35348 2/20 0.84
CYP2C19 P33261 2/20 0.84
KMT2A Q03164 2/20 0.84
MLNR O43193 1/20 0.84
KCNH2 Q12809 1/20 0.84
MEN1 O00255 1/20 0.84
ALDH1A1 P00352 1/20 0.84
CYP2C9 P11712 1/20 0.84
ADCY1 Q08828 14/20 0.67
GMNN O75496 1/20 0.60
BLM P54132 1/20 0.60
PMP22 Q01453 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
CYP2D6 P10635 1/20 0.60
NFKB1 P19838 1/20 0.60
HIF1A Q16665 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7298484 1.00 MAPK1 (0.84) MAPK1CYP3A4TSHRNR1I2ADRA1A
SCHEMBL7295088 0.92 MAPK1 (0.82) MAPK1CYP3A4TSHRNR1I2ADRA1A
SCHEMBL219972 0.91 MAPK1 (1.00) MAPK1CYP3A4TSHRNR1I2ADRA1A
SCHEMBL29397687 0.91 MAPK1 (1.00) MAPK1CYP3A4TSHRNR1I2ADRA1A
SCHEMBL20034151 0.91 MAPK1 (1.00) MAPK1CYP3A4TSHRNR1I2ADRA1A
SCHEMBL23659154 0.91 MAPK1 (1.00) MAPK1CYP3A4TSHRNR1I2ADRA1A
Hydrochloric Acid SCHEMBL2230892 0.91 MAPK1 (0.98) MAPK1CYP3A4TSHRNR1I2ADRA1A
SCHEMBL2233173 0.90 MAPK1 (0.86) MAPK1CYP3A4TSHRNR1I2ADRA1A
Hydrochloric Acid SCHEMBL1651080 0.90 MAPK1 (0.97) MAPK1CYP3A4TSHRNR1I2ADRA1A
SCHEMBL7298674 0.89 MAPK1 (0.76) MAPK1CYP3A4TSHRNR1I2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5206241-A Cardiovascular disorders, reduction of intraocular pressure HOECHST AKTIENGESELLSCHAFT (DE) 1993-04-27 US disclosed
EP-0447962-A1 Labdanes and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1991-09-25 EP disclosed